Hanna, R., Poniwierski, M., Laskey, R., Lopez, M., Shafer, A., Gehrig, P., … Lyman, G. (2011). Predictors and effects of reduced relative dose intensity in women receiving their primary course of chemotherapy for ovarian cancer. In Gynecologic Oncology (Vol. 120, pp. S98–S98). Elsevier BV. https://doi.org/10.1016/j.ygyno.2010.12.234

Hanna, R., M. Poniwierski, R. Laskey, M. Lopez, A. Shafer, P. Gehrig, A. Alvarez-Secord, L. Havrilesky, and G. Lyman. “Predictors and effects of reduced relative dose intensity in women receiving their primary course of chemotherapy for ovarian cancer.” In Gynecologic Oncology, 120:S98–S98. Elsevier BV, 2011. https://doi.org/10.1016/j.ygyno.2010.12.234.

Hanna R, Poniwierski M, Laskey R, Lopez M, Shafer A, Gehrig P, et al. Predictors and effects of reduced relative dose intensity in women receiving their primary course of chemotherapy for ovarian cancer. In: Gynecologic Oncology. Elsevier BV; 2011. p. S98–S98.

Hanna, R., et al. “Predictors and effects of reduced relative dose intensity in women receiving their primary course of chemotherapy for ovarian cancer.” Gynecologic Oncology, vol. 120, Elsevier BV, 2011, pp. S98–S98. Crossref, doi:10.1016/j.ygyno.2010.12.234.

Hanna R, Poniwierski M, Laskey R, Lopez M, Shafer A, Gehrig P, Alvarez-Secord A, Havrilesky L, Lyman G. Predictors and effects of reduced relative dose intensity in women receiving their primary course of chemotherapy for ovarian cancer. Gynecologic Oncology. Elsevier BV; 2011. p. S98–S98.